Follow
Elda Grabocka
Elda Grabocka
Associate Professor, Thomas Jefferson University
Verified email at jefferson.edu - Homepage
Title
Cited by
Cited by
Year
RAS oncogenes: weaving a tumorigenic web
Y Pylayeva-Gupta, E Grabocka, D Bar-Sagi
Nature Reviews Cancer 11 (11), 761-774, 2011
21392011
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
C Commisso, SM Davidson, RG Soydaner-Azeloglu, SJ Parker, ...
Nature 497 (7451), 633-637, 2013
16712013
Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein
JJ Kamphorst, M Nofal, C Commisso, SR Hackett, W Lu, E Grabocka, ...
Cancer research 75 (3), 544-553, 2015
8312015
Mutant KRAS enhances tumor cell fitness by upregulating stress granules
E Grabocka, D Bar-Sagi
Cell 167 (7), 1803-1813. e12, 2016
1722016
Wild-type H-and N-Ras promote mutant K-Ras-driven tumorigenesis by modulating the DNA damage response
E Grabocka, Y Pylayeva-Gupta, MJK Jones, V Lubkov, E Yemanaberhan, ...
Cancer cell 25 (2), 243-256, 2014
1592014
Molecular Pathways: Targeting the Dependence of Mutant RAS Cancers on the DNA Damage Response
E Grabocka, C Commisso, D Bar-Sagi
Clinical cancer research 21 (6), 1243-1247, 2015
532015
Stress granules in cancer
MS Song, E Grabocka
Organelles in Disease, 25-52, 2020
442020
Disruption of oligomerization induces nucleocytoplasmic shuttling of leukemia-associated rho Guanine-nucleotide exchange factor
E Grabocka, PB Wedegaertner
Molecular pharmacology 72 (4), 993-1002, 2007
352007
Stress granules determine the development of obesity-associated pancreatic cancer
G Fonteneau, A Redding, H Hoag-Lee, ES Sim, S Heinrich, MM Gaida, ...
Cancer discovery 12 (8), 1984-2005, 2022
342022
Leukemia-associated RhoGEF (LARG) is a novel RhoGEF in cytokinesis and required for the proper completion of abscission
MK Martz, E Grabocka, N Beeharry, TJ Yen, PB Wedegaertner
Molecular biology of the cell 24 (18), 2785-2794, 2013
332013
Functional consequences of Gα13 mutations that disrupt interaction with p115RhoGEF
E Grabocka, PB Wedegaertner
Oncogene 24 (13), 2155-2165, 2005
322005
Histological image processing features induce a quantitative characterization of chronic tumor hypoxia
A Sundstrom, E Grabocka, D Bar-Sagi, B Mishra
PloS one 11 (4), e0153623, 2016
132016
Mitotic-dependent phosphorylation of leukemia-associated RhoGEF (LARG) by Cdk1
MC Helms, E Grabocka, MK Martz, CC Fischer, N Suzuki, ...
Cellular signalling 28 (1), 43-52, 2016
112016
Stress granules and hormetic adaptation of cancer
A Redding, E Grabocka
Trends in Cancer 9 (12), 995-1005, 2023
92023
RAS-mediated tumor stress adaptation and the targeting opportunities it presents
A Redding, AE Aplin, E Grabocka
Disease Models & Mechanisms 15 (2), dmm049280, 2022
82022
Evaluating stress granules in pancreatic cancer in vitro and in vivo
E Sim, E Irollo, E Grabocka
Pancreatic Cancer: Methods and Protocols, 183-195, 2019
82019
A phase Ib study combining irinotecan with AZD1775, a selective WEE 1 kinase inhibitor, in RAS/RAF mutated metastatic colorectal cancer patients who progressed on first line …
DJ Cohen, E Grabocka, D Bar-Sagi, R Godin, LP Leichman
Journal of Clinical Oncology 35 (15_suppl), TPS3627-TPS3627, 2017
42017
Raf-1 and squamous cell carcinoma: Rok-ing the boat
E Grabocka, D Bar-Sagi
Cancer Cell 16 (2), 85-86, 2009
42009
A Splendid New Beginning at the End of a 40-Year Quest: The First KRASG12D Inhibitor in Pancreatic Cancer
A Redding, E Grabocka
Cancer Discovery 13 (2), 260-262, 2023
22023
Abstract A029: Unfolding the role of cell state on stress granule heterogeneity and function in KRAS-driven pancreatic cancer
A Redding, G Fonteneau, E Grabocka
Molecular Cancer Research 21 (5_Supplement), A029-A029, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20